作者:Aldo Andreani、Mirella Rambaldi、Alberto Leoni、Alessandra Locatelli、Anna Ghelli、Marina Ratta、Bruna Benelli、Mauro Degli Esposti
DOI:10.1021/jm00007a006
日期:1995.3
synthesis of 6-substituted 5-(thienylvinyl)imidazo[2,1-b]thiazoles and 6-thienylimidazo[2,1-b]thiazoles is reported. These compounds were tested as specific inhibitors of the NADH: ubiquinone (UBQ) reductase activity of NADH dehydrogenase in mitochondrial membranes. The 6-thienylimidazo[2,1-b]thiazoles were more potent in mammalian than in nematode mitochondria and had an average titer of 0.11 mM for 2-
报道了6-取代的5-(噻吩乙烯基)咪唑并[2,1-b]噻唑和6-噻吩并咪唑并[2,1-b]噻唑的合成。测试这些化合物作为线粒体膜NADH脱氢酶的NADH特异性抑制剂:泛醌(UBQ)还原酶活性。6-噻吩并咪唑并[2,1-b]噻唑在哺乳动物中比线虫线粒体更有效,并且2-甲基-6-(2-噻吩基)咪唑并[2,1-b]噻唑的平均滴度为0.11 mM。 (10)。该化合物与泛醌底物不竞争,并与鱼藤酮互斥,但与piericidin和其他几种NADH脱氢酶抑制剂互斥,但互斥。在5-(噻吩乙烯基)咪唑并噻唑系列中,(E)-6-氯-5-(2-噻吩乙烯基)咪唑并[2,1-b]噻唑的氢溴酸盐(E-5。